老年慢性心力衰竭患者采取针对性护理干预的临床价值研究

Clinical Value Research of Targeted Nursing Intervention in Elderly Patients with Chronic Heart Failure

探讨老年慢性心力衰竭患者治疗过程中采用针对性护理措施的临床价值。选取成都大学医学院2016年1月至2016年10月收治的120例老年慢性心力衰竭患者，采用前瞻性研究将患者分为研究组和对照组各60例，研究组采用针对性护理措施，对照组采用常规护理措施，两组均采用常规的强心、利尿等基础治疗，对比两组患者的临床效果及生存质量。研究显示，治疗后，研究组患者的LVEDd、NT—proBNP均低于对照组（p〈0．05），研究组的LVEF、SV、6min步行距离均高于对照组（p〈0．05），研究组患者的MLHFQ总分、躯体领域评分、情绪领域评分、其他领域评分均高于对照组（p〈0．os）。治疗过程中，研究组患者的依从性优于对照组0〈0．05）；研究组患者按铃后及时到岗、护理态度、护理技能、住院环境、沟通交流评分均高于对照组（p〈0．05）。老年慢性心力衰竭患者治疗过程中采用针对性护理措施有助于患者治疗依从性的提升、改善患者的生存质量、从而提高临床治疗效果。

To explore the clinical value of targeted nursing measures in the treatment of elderly patients with chronic heart failure, this research selected 120 cases of elderly patients with chronic heart failure treated in Chengdu University College of Medicine from January 2016 to October 2016. Patients were divided into study group and control group, with 60 cases in each group （a prospective study）. The study group was treated with targeted nursing measures, while the control group was treated with routine nursing measures. The two groups were treated with conventional cardiotonics, diuresis and other basic treatments. Clinical efficacy and survival quality of the two groups were compared. The results showed that after treatment, LVEDd and NT-proBNP of patients in the study group were lower than the control group （p〈0.05）, LVEF, SV, and 6 min walking distance of the study group were higher than the control group （p〈0.05）, the scores of MLHFQ, body function domain, emotion function domain, and other domains of patients in the study group were higher than those in the control group （p〈0.05）. During the course of treatment, the compliance of the patients in the study group were better than that of the control group （p〈0.05）. The scores of arriving for duty on time after the bell, nursing attitude, nursing skills, hospital environment and communication of the patients in the study group were all higher than those in the control group （p〈0.05）. Targeted nursing interventions in the treatment of elderly patients with chronic heart failure might contribute to improve therapeutic compliance for patients, and improve the survival quality of patients, so as to improve the clinical effect.